Research Diagnosis Related Groups (DRG) level mortality quality outcomes for New York-Presbyterian Brooklyn Methodist Hospital located at 506 6Th St, Brooklyn, NY, 11215 & includes data from NPIs 1427025352, 1548374549, 1497863740, 1003928144
Dexur analyzed Q4 2016 (October to December 2016) Medicare claims data to benchmark mortality rates for New York-Presbyterian Brooklyn Methodist Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 2,071 | 1,965 | ||||||||||||||||||||||
Surgical | 409 | 392 | ||||||||||||||||||||||
Non Surgical | 1,662 | 1,573 | ||||||||||||||||||||||
Cardiovascular | 390 | 372 | ||||||||||||||||||||||
General Medicine | 349 | 317 | ||||||||||||||||||||||
Gastroenterology & Endocrinology | 229 | 218 | ||||||||||||||||||||||
Orthopedics | 213 | 211 | ||||||||||||||||||||||
Neurology | 182 | 177 | ||||||||||||||||||||||
Urology | 166 | 159 | ||||||||||||||||||||||
Pulmonology | 160 | 154 | ||||||||||||||||||||||
General Surgery | 140 | 127 | ||||||||||||||||||||||
Oncology & Hematology | 106 | 102 | ||||||||||||||||||||||
Psychiatry & Mental Disorders | 71 | 65 | ||||||||||||||||||||||
Colorectal | 18 | 18 | ||||||||||||||||||||||
Obstetrics & Gynecology | 18 | 17 | ||||||||||||||||||||||
Dermatology | 14 | 14 |
Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Heart Failure And Shock | ||||||||||||||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||||||||||||||
DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Syncope And Collapse | ||||||||||||||||||||||||
DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||||||||||||||
Other Circulatory System Diagnoses | ||||||||||||||||||||||||
DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Peripheral Vascular Disorders | ||||||||||||||||||||||||
Hypertension | ||||||||||||||||||||||||
DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other Vascular Procedures | ||||||||||||||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||||||||||||||
Chest Pain | ||||||||||||||||||||||||
DRG 313: CHEST PAIN | ||||||||||||||||||||||||
Acute Myocardial Infarction |
Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 870: SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | ||||||||||||||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Cellulitis | ||||||||||||||||||||||||
DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 602: CELLULITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Rehabilitation | ||||||||||||||||||||||||
DRG 945: REHABILITATION WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Signs And Symptoms | ||||||||||||||||||||||||
Disequilibrium | ||||||||||||||||||||||||
DRG 149: DYSEQUILIBRIUM |
Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
G.I.Hemorrhage | ||||||||||||||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Diabetes | ||||||||||||||||||||||||
DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Other Digestive System Diagnoses | ||||||||||||||||||||||||
G.I. Obstruction | ||||||||||||||||||||||||
Disorders Of Biliary Tract |
Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||||||||||||||
DRG 561: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Medical Back Problems | ||||||||||||||||||||||||
DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||||||||||||||
DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy | ||||||||||||||||||||||||
Fracture, Sprain, Strain And Dislocation Except Femur, Hip, Pelvis And Thigh | ||||||||||||||||||||||||
DRG 563: FRACTURE SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Degenerative Nervous System Disorders | ||||||||||||||||||||||||
DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 056: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||||||||||||||
DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||||||||||||||
DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Seizures | ||||||||||||||||||||||||
DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Cranial And Peripheral Nerve Disorders | ||||||||||||||||||||||||
Other Disorders Of Nervous System |
Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kidney And Urinary Tract Infections | ||||||||||||||||||||||||
DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Renal Failure | ||||||||||||||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Other Kidney And Urinary Tract Diagnoses | ||||||||||||||||||||||||
DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chronic Obstructive Pulmonary Disease | ||||||||||||||||||||||||
DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
Simple Pneumonia And Pleurisy | ||||||||||||||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||||||||||||||
DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Bronchitis And Asthma | ||||||||||||||||||||||||
DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Respiratory System Diagnosis With Ventilator Support | ||||||||||||||||||||||||
Pulmonary Embolism |
Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Other Respiratory System O.R. Procedures | ||||||||||||||||||||||||
Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck |
Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Red Blood Cell Disorders | ||||||||||||||||||||||||
DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Respiratory Neoplasms | ||||||||||||||||||||||||
DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||||||||||||||
Malignancy Of Hepatobiliary System Or Pancreas | ||||||||||||||||||||||||
DRG 435: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||||||||||||||
DRG 885: PSYCHOSES | ||||||||||||||||||||||||
Organic Disturbances And Intellectual Disability | ||||||||||||||||||||||||
DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY |
Total Hospitalizations (Oct 2016 to Dec 2016) | Total Hospitalizations After Exclusion | Total Users | In Hospital Mortality Rate (%) | 30 Day Mortality Rate (%) | 60 Day Mortality Rate (%) | 90 Day Mortality Rate (%) | 1 Year Mortality Rate (%) | New York Total Hospitalizations (Oct 2016 to Dec 2016) | New York Total Hospitalizations After Exclusion | New York Total Users | New York In Hospital Mortality Rate (%) | New York 30 Day Mortality Rate (%) | New York 60 Day Mortality Rate (%) | New York 90 Day Mortality Rate (%) | New York 1 Year Mortality Rate (%) | National Total Hospitalizations (Oct 2016 to Dec 2016) | National Total Hospitalizations After Exclusion | National Total Users | National In Hospital Mortality Rate (%) | National 30 Day Mortality Rate (%) | National 60 Day Mortality Rate (%) | National 90 Day Mortality Rate (%) | National 1 Year Mortality Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures |